Scotiabank analyst Louise Chen maintained a Buy rating on Zai Lab (ZLAB – Research Report) today and set a price target of $55.00. The ...

Scotiabank analyst Louise Chen maintained a Buy rating on Gain Therapeutics (GANX – Research Report) today and set a price target of $12.00.

Learn more about whether Moderna, Inc. or Zai Lab Limited is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

LLC have described poly(ADP-ribose) glycohydrolase (PARG) inhibitors reported to be useful for the treatment of cancer.

Meeting to be held in Frankfurt, Germany on April 8, in Stockholm, Sweden on April 9 and in Paris, France on April 10 hosted by Cantor ...

Scotiabank analyst Louise Chen maintained a Hold rating on Sarepta Therapeutics (SRPT – Research Report) today and set a price target of ...

Max, formerly known as HBO Max, officially has a new logo on Sunday night, March 30. The new logo for Warner Bros. Discovery's steaming platform was unveiled on Sunday evening. The new logo gives ...

NASDAQ:ZLAB opened at $37.29 on Thursday. Zai Lab has a 52 week low of $13.48 and a 52 week high of $39.77. The stock has a market cap of $4.09 billion, a price-to-earnings ratio of -13.46 and a ...

Zai Lab Limited (NASDAQ:ZLAB) stock has reached a new 52-week high, touching $39.66 amidst a period of significant growth.

Rocket Lab USA (RKLB) stock soared over 9% in pre-market trading on Friday after it made a bold entry into the U.S. Space Force’s National Security Space (NSS) launch competition. Alongside ...

TOKYO, March 27, 2025--(BUSINESS WIRE)--The Japan Spirits & Liqueurs Makers Association (JSLMA) announced the adoption of a new logo to reinforce their "Standards for Labeling Japanese Whisky ...